PathAI logo

From Pixels to Precision: Launch!

In the ever-evolving landscape of pathology, the digital frontier is now upon us, revolutionizing the way we perceive, process, and diagnose. Gone are the days when digital pathology was confined to research and biopharma. With the pandemic propelling the need for remote consultations and telepathology into the spotlight, a new era has dawned where digital pathology has increasing power and application within routine pathology workflows.

Earlier this week, PathAI CEO, Andy Beck, wrote a letter highlighting PathAI’s philosophy for expanding digital pathology into the anatomic laboratory solutions space, on the heels of our latest announcement introducing the launch of AISight Image Management System. Laboratories worldwide are seizing the opportunity to adapt, adopting cutting-edge scanners and creating digital laboratories to meet the demands of a rapidly changing world.

These digital laboratories are now not just repositories of slides but launchpads for innovation. By embracing digital pathology, anatomic pathology laboratories are uncovering new ways to conduct research, optimize the workflow, and unlock the gateway to harnessing artificial intelligence applications. While these applications may be many and new, they are already catalyzing research, expediting biomarker discovery, optimizing workflow efficiency, and quantifying vital biomarkers with precision. The synergy between technology and medical insight has never been more potent.

Yet the landscape is complex. While it may seem that every conference echoes with a new laboratory highlighting its transformational journey of digitalization, the steps to digitalization are not easy. There is an alphabet soup of terms to navigate that traverse the boundaries of technology and medicine. Cloud-based storage. Dynamic pre-fetch. Bidirectional integrations. Additive multiple instance learning. Convolutional neural networks. On top of that, the ecosystem is complex. It almost seems as if there’s a new digital pathology company popping up every week, often creating a paralysis of choice for many laboratories that are early in their journey to full-scale digitization of routine pathology.

We’ve been there. PathAI operates the third-largest independent anatomic pathology laboratory in the United States called PathAI Diagnostics, processing more than 500,000 cases a year across dermatopathology, genitourinary, gastrointestinal, and women’s health use cases. It’s hard to run a laboratory and simultaneously transition to digital while trying to make sense of what it truly means to digitize a laboratory. We’ve made mistakes. It’s almost inevitable. But over the past two years, we’ve also learned a tremendous amount.

Watch this video of our PathAI Diagnostics Lab

Now we’re excited to share these lessons with the rest of the world with the launch of a new blog series called “From Pixels to Precision”. In this weekly series, we will follow the journey and decision-making that a laboratory sequentially goes through when deciding to digitalize. How do you decide whether to store data in the cloud or on-premise and for how long? What does the landscape of laboratory information systems look like that can work well and integrate well with image management systems? What’s the importance of deploying artificial intelligence from the first day that a lab goes digital? How do you go about choosing the right partners and vendors? How do you build a business case for digitalization?

We’ve learned so much by listening to pathologists and by walking the talk in our own laboratory. We are excited to share these insights with the global community and provide a beacon for navigating this important field.


1 AISight is for Research Use Only. Not for use in diagnostic procedures.

Get In Touch

Please contact [email protected] if you would like to learn more about PathAI's AISight IMS platform and AI applications.
Path AI seating area overlooking Fenway Park in Boston